Advanced therapeutics, such as cell engineering, gene therapy, and immune engineering, comprise the next generation of life-enhancing and curative interventions. As new therapies gain approval, the ...

Ace Therapeutics announced custom animal models of hypertension, designed to help understand hypertension pathogenesis ...

AUSTIN, TX, UNITED STATES, September 20, 2025 /EINPresswire.com/ -- According to DataM Intelligence, the next generation antibody therapeutics market size reached US ...

The American Society of Health-System Pharmacists is launching the ASHP Center for Next-Generation Therapeutics, a new initiative supporting hospital and health-system pharmacy in navigating the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--NextPoint Therapeutics, a clinical-stage biotechnology company launching a new world of precision therapeutics through its leading scientific work on the novel B7-H7 ...

TARPON SPRINGS, Fla., August 26, 2025 -- Allarity Therapeutics, Inc. (ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT ...

Allarity Therapeutics, Inc. announced that it has enrolled the first patient in a new Phase 2 clinical trial for stenoparib, a dual PARP and WNT pathway inhibitor, aimed at treating advanced, platinum ...

CytomX reports promising Phase 1 data for CX-2051 in advanced colorectal cancer, with planned Phase 2 study in 2026. CytomX Therapeutics announced positive interim results from its Phase 1 study of CX ...

TARPON SPRINGS, Fla., June 2, 2025 -- Allarity Therapeutics, Inc. (ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway ...

Ozempic has been making headlines for its remarkable success in treating obesity and diabetes. Yet it is just one in a rapidly growing class of drugs called peptide therapeutics that sits between ...